PERRIGO (NASDAQ:PRGO)
45.78
0.54 (1.17%)
| PERRIGO (NASDAQ:PRGO) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $46.32 | 52 Week High | $46.90 | ||
| Open | $46.27 | 52 Week Low | $18.54 | ||
| Day High | $46.27 | P/E | 25.86 | ||
| Day Low | $45.76 | EPS | $1.77 | ||
| Volume | 100,675 | ||||
| More PRGO Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| TASE | 4 | BP | 3 |
| ADSK | 3 | ARM | 3 |
| VRSN | 3 | MHS | 3 |
| UNM | 3 | MCO | 3 |
| ATHN | 3 | EVR | 3 |
| POT | 3 | ADS | 3 |
Entities who have mentioned PRGO
- Credit Suisse | View Related Stories »
- UBS | View Related Stories »
- Dividend | View Related Stories »
- Citi | View Related Stories »
- Matrix USA | View Related Stories »
- Goldman Sachs | View Related Stories »
- Morgan Stanley | View Related Stories »
- JPMorgan | View Related Stories »
- Trading Radar | View Related Stories »
- KeyBanc | View Related Stories »
- Needham & Company | View Related Stories »
- Collins Stewart | View Related Stories »
- Scopia Capital | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
- Soleil Securities | View Related Stories »
- David Moenning | View Related Stories »
- Crude Oil | View Related Stories »
- HSBC | View Related Stories »
- Vanguard | View Related Stories »
- Initial Jobless Claims | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- 13D | View Related Stories »
- 13G | View Related Stories »
- Keefe, Bruyette & Woods | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
View All Major News StreetInsider.com Major News for PRGO
- Perrigo (PRGO) Reports Mixed Q2 Results; Raises FY10 EPS Guidance
- Perrigo Co. (PRGO) Tops Q1 EPS Views, Posts $0.66; Raises FY10 EPS Guidance
- Perrigo (PRGO) Tops Q3 Views; Raises FY10 Outlook
View All ReportsStreetInsider.com Reports on PRGO
- Caris & Co Upgrades Perrigo (PRGO) to Above Average
- Perrigo (PRGO) Reports Mixed Q2 Results; Raises FY10 EPS Guidance
- Trading Radar for 02/02: Dow Chemical (DOW), Hershey (HSY), Marathon Oil (MRO), MetLife (MET), Radware (RDWR) Reports
- Needham & Co Initiates Coverage on Perrigo (PRGO) with a Hold
- Perrigo (PRGO) Files Abbreviated NDA for Generic Clobex Spray; Announces Galderma Lawsuit
View All Press ReleasesCompany Press Releases on PRGO
- Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
- Perrigo Company Announces Quarterly Dividend
- Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
- Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
- Last Day to Vote for the Best IR Program and Best IR Officer
StreetInsider Reports on PRGO by Category
View All BlogsBlogs on PRGO
- Perrigo, EV3: Two Attractive Healthcare Stocks
- 10 Dividend Growers Impervious to the Downturn
- How to Stress Test Your ETFs
- Analyst upgrades, downgrades and initiations: ABT, BA, CLWR, LLY, LTD, NFLX ...
- Perrigo: Worth Holding Onto
View All FilingsSEC Filings on PRGO
- Form 10-Q PERRIGO CO For: Dec 26
- Form 8-K PERRIGO CO For: Feb 02
- Form SC 13G PERRIGO CO Filed by: BlackRock Inc.
- Form SC 13D/A PERRIGO CO Filed by: Arkin Moshe
Comments on recent PRGO articles
Comments on PRGO
No comments are currently available.
on Apr 1, 2008
at 12:23 AM FREE ZYRTEC-D ON SOCIAL SECURITY
Article: Perrigo (PRGO) to Market Generic Zyrtec-D